Jensen Investment Management Portfolio in 2026: Top Holdings & Recent Changes
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Jensen Investment Management continues to showcase its disciplined growth-at-a-reasonable-price strategy through active portfolio management. Their $6.4B portfolio in Q4 2025 reflects significant trims in legacy tech leaders alongside bold new bets on high-growth names like Amazon and NVIDIA, signaling a pivot toward AI-driven innovation amid market rotations.
Portfolio Snapshot: Disciplined Growth in a Tech-Heavy World
Portfolio Highlights (Q4’2025): - Market Value: $6,355.9M - Top 10 Holdings: 56.9% - Portfolio Size: 89 +2 - Average Holding Period: 27 quarters - Turnover: 13.5%
Jensen Investment Management's Q4 2025 portfolio maintains a hallmark balance of concentration in top-tier growth names while diversifying across 89 positions, a slight increase of two new holdings. The top 10 holdings command 56.9% of the portfolio, underscoring a high-conviction approach that favors quality compounders over broad market exposure. With an impressive average holding period of 27 quarters—over six years—this reflects the firm's patient, long-term orientation rather than reactive trading.
Turnover at 13.5% indicates measured activity, allowing the team led by Eric Schoenstein to refine positions without disrupting core convictions. This portfolio structure suits investors seeking exposure to proven innovators, as the firm trims overvalued leaders to fund emerging opportunities. Tracking these shifts via Jensen's portfolio page on ValueSense reveals a strategy attuned to valuation discipline amid tech sector volatility.
The expansion to 89 holdings +2 suggests ongoing opportunity scouting beyond megacaps, potentially in smaller growth stories that align with their quality focus. This evolution keeps the portfolio dynamic yet anchored, balancing risk through long holding periods and selective turnover.
Core Positions: Major Trims in Magnificent Seven, Fresh AI and E-Commerce Bets
The portfolio's foundation remains tech-dominant, led by Microsoft (MSFT) at 10.1% after a Reduce 12.68% trim, followed closely by Apple (AAPL) at 8.5% with a Reduce 14.11% adjustment, and Alphabet (GOOGL) at 7.5% down Reduce 14.46%. These moves signal profit-taking in high-flyers potentially facing valuation pressures. Bright spots include NVIDIA (NVDA) at 6.6%, boosted by an Add 4.33% amid AI enthusiasm, and a bold new Amazon (AMZN) "Buy" position at 4.1% worth $261.7M, highlighting conviction in cloud and e-commerce resilience.
Significant reductions continue in quality growth names like Mastercard (MA) at 4.3% (Reduce 16.99%), Eli Lilly (LLY) at 4.2% slashed Reduce 46.13%, and Stryker (SYK) at 4.0% (Reduce 40.04%), suggesting reallocation from healthcare and payments to higher-upside tech. Meta Platforms (META) holds at 3.8% after Reduce 8.47%, while Abbott Laboratories (ABT) at 3.7% saw Reduce 22.26%. These 10 positions, all with notable changes, dominate the changes narrative and comprise the entire top 10, reflecting comprehensive portfolio rebalancing.
This flowing adjustment across the top holdings—from trimming mature leaders to adding AI and e-commerce exposure—demonstrates Jensen's adaptive growth strategy without abandoning core quality screens.
What the Portfolio Reveals: Quality Growth with Valuation Discipline
Jensen Investment Management's moves paint a clear picture of a quality-over-speculation ethos, prioritizing durable competitive moats in technology and healthcare while enforcing valuation discipline through aggressive trims.
- Tech Sector Dominance: Over 50% implied exposure via top holdings like MSFT, AAPL, GOOGL, NVDA, AMZN, and META underscores belief in digital transformation, but trims signal caution on peak valuations.
- AI and Innovation Pivot: The NVDA add and AMZN buy highlight forward-looking bets on semiconductors and cloud/AI infrastructure, positioning for multi-year growth cycles.
- Healthcare Balance: Reductions in LLY, SYK, and ABT suggest profit-taking after strong runs, maintaining exposure without overconcentration.
- Risk Management: 13.5% turnover and 27-quarter holds show patience, with portfolio size expansion mitigating single-stock risks.
- U.S.-Centric Focus: All top holdings are domestic giants, reflecting confidence in American innovation amid global uncertainties.
This thematic clarity—trimming winners to buy dips in high-conviction growth—offers a blueprint for navigating tech rotations.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
Portfolio Concentration Analysis
| Position | Value | % of Portfolio | Recent Change |
|---|---|---|---|
| Microsoft Corporation (MSFT) | $641.7M | 10.1% | Reduce 12.68% |
| Apple Inc. (AAPL) | $537.8M | 8.5% | Reduce 14.11% |
| Alphabet Inc. (GOOGL) | $479.6M | 7.5% | Reduce 14.46% |
| NVIDIA Corporation (NVDA) | $420.3M | 6.6% | Add 4.33% |
| Mastercard Incorporated (MA) | $275.6M | 4.3% | Reduce 16.99% |
| Eli Lilly and Company (LLY) | $268.5M | 4.2% | Reduce 46.13% |
| Amazon.com, Inc. (AMZN) | $261.7M | 4.1% | Buy |
| Stryker Corporation (SYK) | $257.1M | 4.0% | Reduce 40.04% |
| Meta Platforms, Inc. (META) | $241.6M | 3.8% | Reduce 8.47% |
| Abbott Laboratories (ABT) | $234.7M | 3.7% | Reduce 22.26% |
This table reveals extreme concentration risk-reward in Jensen's approach, with the top three holdings (MSFT, AAPL, GOOGL) alone comprising over 26% despite significant reductions averaging 13-14%. The strategy shines in selective adds like NVDA +4.33% and the outright AMZN buy, offsetting massive trims in healthcare (LLY -46.13%, SYK -40.04%) to maintain balance.
Overall, 56.9% in just 10 names enables outsized gains from winners but demands precise timing—evident in the low 13.5% turnover preserving long-term holds while freeing capital for opportunistic shifts.
Investment Lessons from Jensen Investment Management's Growth Discipline
Jensen Investment Management's Q4 2025 actions distill timeless principles for growth investing:
- Trim winners ruthlessly: Reductions in MSFT 12.68%, AAPL 14.11%, and GOOGL 14.46% show discipline in taking profits near peaks, preventing valuation traps.
- Long holding periods build wealth: 27 quarters average tenure proves patience with quality compounders outweighs short-term noise.
- Bet big on moats with momentum: NVDA add and AMZN buy exemplify doubling down on AI/cloud leaders when fundamentals align.
- Diversify thoughtfully: 89 positions +2 balance top-10 concentration 56.9%, adding resilience without diluting returns.
- Quality trumps cheapness: Healthcare trims (LLY, SYK) prioritize growth potential over static value, aligning with their GARP philosophy.
These lessons empower retail investors to emulate professional position sizing via tools like ValueSense.
Looking Ahead: What Comes Next?
Jensen's trims have likely generated substantial cash for deployment, with turnover at 13.5% and +2 positions hinting at ongoing scouting in AI adjacencies or undervalued growth. The AMZN buy and NVDA add position the portfolio for cloud/AI tailwinds, potentially amplifying returns if tech rotations favor innovators over legacy names.
Market conditions—elevated valuations post-2025 rallies—favor their valuation-aware approach, with opportunities in semis, e-commerce, and healthcare dips. Current weighting sets up for 2026 upside if economic resilience holds, though further trims could signal caution on overextended megacaps. Monitor Jensen's portfolio for Q1 signals.
FAQ about Jensen Investment Management Portfolio
Q: What are the biggest changes in Jensen Investment Management's Q4 2025 13F filing?
A: Major trims dominated, including Eli Lilly (Reduce 46.13%), Stryker (Reduce 40.04%), and Mastercard (Reduce 16.99%), alongside adds in NVIDIA (Add 4.33%) and a new Amazon buy, reflecting profit-taking and AI/e-commerce conviction.
Q: Why does Jensen's portfolio concentrate 56.9% in just 10 holdings?
A: This high-conviction strategy leverages deep research on quality growth leaders like MSFT and NVDA, balancing risk via 89 total positions and long 27-quarter holds for compounded returns.
Q: What sectors dominate Jensen Investment Management's strategy?
A: Technology rules with MSFT, AAPL, NVDA, AMZN, and META, complemented by healthcare (LLY, SYK, ABT), emphasizing U.S.-based innovators in AI, cloud, and medtech.
Q: How can I track Jensen Investment Management's portfolio like a pro?
A: Use ValueSense's superinvestor tracker at https://valuesense.io/superinvestors/jensen-investment for real-time 13F updates—note the 45-day filing lag—and analyze holdings with our intrinsic value tools.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2026)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!